Skip NavigationSkip to Content
Return Return to Search Results

Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale

  1. Author:
    Stumpel, D.
    Schotte, D.
    Lange-Turenhout, E. A. M.
    Schneider, P.
    Seslija, L.
    de Menezes, R. X.
    Marquez, V. E.
    Pieters, R.
    den Boer, M. L.
    Stam, R. W.

  2. Author Address

    [Stumpel, D. J. P. M.; Schotte, D.; Lange-Turenhout, E. A. M.; Schneider, P.; Seslija, L.; de Menezes, R. X.; Pieters, R.; den Boer, M. L.; Stam, R. W.] Erasmus MC, Sophia Childrens Hosp, Dept Pediat Oncol Hematol, NL-3015 GE Rotterdam, Netherlands. [Marquez, V. E.] NCI, Biol Chem Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA.;Stam, RW, Erasmus MC, Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Room Ee15-14A,Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.;r.stam@erasmusmc.nl
    1. Year: 2011
    2. Date: Mar
  2. Journal: Leukemia
    1. 25
    2. 3
    3. Pages: 429-439
  4. Type of Article: Article
  5. ISSN: 0887-6924
  1. Abstract:

    MLL-rearranged acute lymphoblastic leukemia (ALL) in infants (< 1 year) is the most aggressive type of childhood leukemia. To develop more suitable treatment strategies, a firm understanding of the biology underlying this disease is of utmost importance. MLL-rearranged ALL displays a unique gene expression profile, partly explained by erroneous histone modifications. We recently showed that t(4;11)-positive infant ALL is also characterized by pronounced promoter CpG hypermethylation. In this study, we investigated whether this widespread hypermethylation also affected microRNA (miRNA) expression. We identified 11 miRNAs that were downregulated in t(4;11)-positive infant ALL as a consequence of CpG hypermethylation. Seven of these miRNAs were re-activated after exposure to the de-methylating agent Zebularine. Interestingly, five of these miRNAs are associated either with MLL or MLL fusions, and for miR-152 we found both MLL and DNA methyltransferase 1 (DNMT1) as potential targeted genes. Finally, a high degree of methylation of the miR-152 CpG island was strongly correlated with a poor clinical outcome. Our data suggests that inhibitors of methylation have a potential beyond re-expression of hypermethylated protein-coding genes in t(4;11)-positive infant ALL. In this study, we provide additional evidence that they should be tested for their efficacy in MLL-rearranged infant ALL in in vivo models. Leukemia (2011) 25, 429-439; doi:10.1038/leu.2010.282; published online 30 November 2010

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1038/leu.2010.282
  3. View record in Web of Science®
  4. WOS: 000288159500005

Library Notes

  1. Fiscal Year: FY2010-2011
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel